Neimeth International Pharmaceuticals Dividend
What is Neimeth International Pharmaceuticals's current dividend yield, its reliability and sustainability?
Dividend Score 1/6
Cash Flow Coverage
Current Dividend Yield
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: Whilst dividend payments have been stable, NEIMETH has been paying a dividend for less than 10 years.
Growing Dividend: NEIMETH's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
|Neimeth International Pharmaceuticals Dividend Yield vs Market|
|Market Bottom 25% (NG)||3.7%|
|Market Top 25% (NG)||8.0%|
|Industry Average (Pharmaceuticals)||2.5%|
|Analyst forecast in 3 Years (NEIMETH)||n/a|
Notable Dividend: NEIMETH's dividend (4.49%) is higher than the bottom 25% of dividend payers in the NG market (3.67%).
High Dividend: NEIMETH's dividend (4.49%) is low compared to the top 25% of dividend payers in the NG market (8.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (255.2%), NEIMETH's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: NEIMETH is paying a dividend but the company has no free cash flows.